NBIX technical analysis
NBIX Technical Analysis
Analysis date
August 7, 2026
Market
NasdaqGS (USD)
Daily cutoff
August 6, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
NBIX Data Verification
Checking the latest completed daily bar for date and closing-price consistency before indicators are calculated.
- Symbol
- NBIX
- Market
- NasdaqGS
- Currency
- USD (US Dollar)
- Latest completed bar
- August 6, 2026
Historical prices are adjusted for corporate actions when applicable. Date and closing-price consistency checks passed for the latest completed daily bar.
| Validation series | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Calculation series | 159.82 | August 6, 2026 | - | Verified |
| Verification series | 159.82 | August 6, 2026 | 0.00% | Verified |
Bottom line
NBIX Technical Analysis Summary
NBIX (Neurocrine Biosciences) shows a mixed technical picture after a sharp pullback from the recent high. On the daily chart, price at 159.82 has fallen below SMA20 (172.92) and SMA50 (167.97) while still holding above SMA200 (146.42). RSI14 at 37.92 sits below the 50 midline, and the MACD line at -0.80 has crossed below the signal line at 1.67 with a negative histogram of -2.47, pointing to weakening short-term momentum. The weekly chart remains structurally bullish with price at 166.80 above SMA20 (152.51), SMA50 (145.09), and SMA200 (126.36), though the latest completed week closed lower on well above average volume. Key support sits at 158.48 (20-period low) and 146.42 (SMA200), while resistance stands at 167.97 (SMA50), 172.92 (SMA20), and 186.12 (52-week high). The near-term bias is cautious until price reclaims the daily moving averages, while the longer-term trend stays intact as long as weekly price holds above SMA20 at 152.51.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (August 6, 2026)
- Trend
- Mixed to cautious. Price at 159.82 is below SMA20 (172.92, -7.58%) and SMA50 (167.97, -4.85%) but above SMA200 (146.42, +9.15%). The SMA20 sits above SMA50 above SMA200, so the longer-term moving average structure remains positive, but price has broken below the near-term averages, signaling a pullback within the broader uptrend.
- Momentum
- Weak. RSI14 at 37.92 is below the 50 midline, reflecting fading upward momentum after the recent selloff. The MACD line at -0.80 is below the signal line at 1.67 with a negative histogram of -2.47, confirming a bearish crossover. RSI near 37 is not yet oversold, so additional downside is possible before buyers step in.
- Volatility
- Elevated. ATR14 at 6.07 is 3.80% of price, reflecting wider daily swings during the pullback. Bollinger Bands range from 159.99 to 185.84, and price at 159.82 is pressing against the lower band, which can accompany sharp short-term moves.
- Volume
- Near average. Latest volume of 1,365,918 is about 98.7% of the 20-period average of 1,383,496. Participation is roughly in line with the recent mean, without a capitulation spike or a strong accumulation signal.
Assessment
The daily chart has turned defensive. Price is below the key short-term averages, momentum has shifted negative, and the stock is testing the 158.48 (20-period low) support zone near the lower Bollinger Band. A hold above SMA200 at 146.42 keeps the long-term uptrend intact. A decisive close below 158.48 would open the door to a deeper move toward 150.82 (60-period low) and SMA200. The near-term risk is mean-reversion lower; the upside case requires a reclaim of SMA50 at 167.97 and then SMA20 at 172.92.
Weekly (July 27, 2026 week)
- Trend
- Bullish. Price at 166.80 is above SMA20 (152.51, +9.37%), SMA50 (145.09, +14.96%), and SMA200 (126.36, +32.00%). The weekly moving averages remain in bullish alignment with positive slopes, confirming the structural uptrend despite the recent pullback.
- Momentum
- Positive but moderating. RSI14 at 59.45 is still above the 50 midline, leaving room before overbought territory. The MACD line at 9.66 is above the signal line at 7.81 with a positive histogram of 1.85, though the latest week closed lower by 5.10%, so momentum is cooling from an extended level.
- Volatility
- Moderate to elevated. ATR14 at 10.22 is 6.13% of price, normal for a mid-cap biotech but rising with the recent volatility. Bollinger Bands span 116.92 to 188.10, and price is above the band midpoint, in the upper half of the weekly range.
- Volume
- Well above average. Weekly volume of 10,208,000 is 1.74 times the 20-week average of 5,857,430, indicating heavy participation during the pullback week. Selling on elevated volume can precede continued short-term pressure.
Assessment
The weekly structure remains bullish: price is above all major weekly moving averages and the 52-week position is 69.80%. However, the latest completed week posted a 5.10% loss on well above average volume, and RSI has rolled over from an extended level. As long as weekly price holds above SMA20 at 152.51, the uptrend is intact. A weekly close below 152.51 would shift the primary trend outlook from bullish to neutral.
Key indicators
NBIX Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 37.92 | 59.45 |
| MACD (12, 26, 9) | -0.80 / 1.67 / -2.47 | 9.66 / 7.81 / 1.85 |
| ATR (14) | 6.07 (3.80%) | 10.22 (6.13%) |
| Bollinger Bands (20, 2) | 159.99 - 185.84 | 116.92 - 188.10 |
| SMA (20) | 172.92 | 152.51 |
| SMA (50) | 167.97 | 145.09 |
| SMA (200) | 146.42 | 126.36 |
Price structure
NBIX Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 159.82 | 166.80 |
| 1-Period Return | -1.04% | -5.10% |
| 5-Period Return | -13.84% | -1.02% |
| 20-Period Return | -11.48% | +28.53% |
| 60-Period Return | +6.13% | +33.03% |
| 252-Period Return | +24.48% | +64.40% |
| 52-Week Low | 122.14 | 122.14 |
| 52-Week High | 186.12 | 186.12 |
| 52-Week Position | 58.89% | 69.80% |
Key levels
NBIX Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 186.12 | 186.12 |
| 20-Period Low | 158.48 | 125.11 |
| 60-Period High | 186.12 | 186.12 |
| 60-Period Low | 150.82 | 122.14 |
Scenarios
NBIX Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price reclaims SMA50 at 167.97 and then SMA20 at 172.92 on rising volume, setting up a retest of the 52-week high at 186.12. A weekly close back above SMA20 at 152.51 reinforces a resumption of the uptrend.
Invalidation
A daily close below the 20-period low at 158.48, which would indicate the pullback is deepening rather than resolving higher.
What to watch
Daily RSI recovering above 50; MACD histogram turning less negative; volume contracting on down days; Ingrezza prescription trends and pipeline updates; quarterly earnings results and biotech sector sentiment.
Consolidation
Trigger
Price holds between 158.48 (20-period low) and 172.92 (SMA20), digesting the drop from the recent high while RSI rebuilds between 35 and 55.
Invalidation
A decisive break below 158.48 or above 186.12 with increasing volume.
What to watch
RSI stabilizing above 30; Bollinger Band width flattening; volume normalizing toward the 20-period average; regulatory news and pipeline milestones.
Bearish
Trigger
Price closes below 158.48 (20-period low) and then SMA200 at 146.42, which would break the long-term moving average support and point toward the 60-period low at 150.82 and lower.
Invalidation
Price reclaims SMA50 at 167.97 and forms a higher low above 158.48.
What to watch
Daily RSI falling toward 30; MACD staying below the signal line; volume expanding on down days; competitive pressure on Ingrezza and setbacks for the neurology pipeline.
Methodology
Methodology and Limitations
This technical analysis is calculated locally from adjusted OHLCV history. The daily series ends August 6, 2026, and the weekly series ends July 27, 2026 week. The latest completed daily bar is independently checked for date and closing-price consistency. Historical prices are adjusted for corporate actions when applicable. Indicators include Wilder RSI(14), MACD(12,26,9), SMA20/50/200, Wilder ATR(14), Bollinger Bands(20,2), relative volume, multi-period returns, and price-range levels. Support and resistance are descriptive zones, not guaranteed reversal points. Historical patterns do not predict future prices, and this page is not investment advice.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Market data is checked for date and closing-price consistency before indicators are calculated. Data cutoffs: daily August 6, 2026, weekly July 27, 2026 week. Generated August 7, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.